GlassScriptPhysician profile
Edward Gettings
NPI 1427367499
$7,605.69
in general payments reported to CMS, 2019-2025
10 companies · $7,347 in 2025
The $7,347 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.50 · 2023: $171 · 2024: $34.08 · 2025: $7,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,675 · Food and Beverage: $509 · Travel and Lodging: $340 · Education: $28.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,675.00 |
| Food and Beverage | $508.65 |
| Travel and Lodging | $339.91 |
| Education | $28.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $7,165.98 | 2025 | Ocrevus, Ocrevus Zunovo |
| Biogen, INC. | $203.50 | 2021-2023 | Tysabri |
| Genentech, INC. | $87.56 | 2025 | Ocrevus |
| Abbvie INC. | $67.69 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $34.08 | 2024 | |
| Amgen INC. | $28.63 | 2025 | Uplizna |
| Vanda Pharmaceuticals INC. | $18.25 | 2025 | Ponvory |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Gettings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.